×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: covid | omicron | BioNTech | Pfizer | shot | delay

BioNTech: Regulatory Requirements May Delay Omicron Shot Launch to After March

vials labeled COVID-19 vaccine with logos of Pfizer and BioNTech in background
(Dreamstime)

Tuesday, 25 January 2022 09:37 AM

BioNTech said it and partner Pfizer may not be able to stick with their plan to launch an omicron-targeting vaccine by the end of March, depending on how much clinical trial data regulators will require.

"Regulatory requirements are currently under discussion with the relevant authorities. Inclusion of clinical trial data in the regulatory filings may have an impact on the delivery of initial batches, currently expected to be ready by end of March," a spokesperson told Reuters on Tuesday.

Pfizer and BioNTech said earlier they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. 

© 2022 Thomson/Reuters. All rights reserved.


Health-News
BioNTech said it and partner Pfizer may not be able to stick with their plan to launch an omicron-targeting vaccine by the end of March, depending on how much clinical trial data regulators will require. "Regulatory requirements are currently under discussion with the...
covid, omicron, BioNTech, Pfizer, shot, delay
119
2022-37-25
Tuesday, 25 January 2022 09:37 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved